Cargando…
The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study was to evaluate the efficacy of novel Nox inhibitors as protective agents against cytokine- or high glucose + palmit...
Autores principales: | Wang, Xuan, Elksnis, Andris, Wikström, Per, Walum, Erik, Welsh, Nils, Carlsson, Per-Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161897/ https://www.ncbi.nlm.nih.gov/pubmed/30265686 http://dx.doi.org/10.1371/journal.pone.0204271 |
Ejemplares similares
-
Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells
por: Elksnis, Andris, et al.
Publicado: (2021) -
The loss of pancreatic islet NADPH oxidase (NOX)2 improves islet transplantation
por: Wrublewsky, Selina, et al.
Publicado: (2022) -
Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets
por: Olerud, Johan, et al.
Publicado: (2008) -
Activated pancreatic stellate cells can impair pancreatic islet function in mice
por: Zang, Guangxiang, et al.
Publicado: (2015) -
GLX351322, a Novel NADPH Oxidase 4 Inhibitor, Attenuates TMJ Osteoarthritis by Inhibiting the ROS/MAPK/NF-κB Signaling Pathways
por: Zhen, Jinze, et al.
Publicado: (2023)